Soma Subramaniam serves as the Global Medical Director for Hepatobiliary and Pancreatic Cancer at Natera since September 2025 and has been a Medical Oncologist at Swedish Medical Center since July 2014, focusing on gastrointestinal cancers and patient education regarding treatment options. Previously, Soma held the position of Director of Oncology Medical Development at Exact Sciences from February 2024 to September 2025 and was the Medical Director of the Cancer Control Program at Swedish Cancer Institute from March 2016 to February 2024, emphasizing cancer eradication and early diagnosis. Clinical training as a Fellow Physician in Medical Oncology occurred at Stanford University Medical Center from July 2011 to June 2014, with prior residency in Internal Medicine at the University of Hawaii from July 2008 to June 2011. Education includes a Master of Science in Epidemiology and Clinical Research from Stanford University School of Medicine and a Bachelor of Medicine, Bachelor of Surgery from the National University of Singapore.
This person is not in any teams
This person is not in any offices